Bruker Corp

Bruker Corp

BRKR

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.07B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bruker CorpBruker Corp-85.20.34%-3%2.61
$53.83

Target Price by Analysts

5.3% downsideBruker Target Price DetailsTarget Price
$10.63

Current Fair Value

81.3% downside

Overvalued by 81.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.07 Billion
Enterprise Value$11.24 Billion
Dividend Yield$0.20 (0.34%)
Earnings per Share$-0.15
Beta1.28
Outstanding Shares152,200,000

Return

Return on Equity-2.97%ROE
Return on Assets-1.18%
Return on Invested Capital0.51%

Valuation & Multiples

P/E Ratio-85.21P/E Ratio
PEG10.87PEG
Price to Sales2.58Price to Sales
Price to Book Ratio3.79Price to Book Ratio
Enterprise Value to Revenue3.21
Enterprise Value to EBIT458.86
Enterprise Value to Net Income-158
Total Debt to Enterprise0.21
Debt to Equity0.98Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectation
Revenue Estimate
$853.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$0.42
Average shareholder expectation
Revenue Estimate
$867.35 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1234 65.42%
Total Calls1,536,900 609.23%
Total Puts189,600 12.52%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %99.19% 9.00%
Total Invested$8.72B 76.35%
Investors Holding429 77.00%

ESG Score

No data

About Bruker Corp

6,000 employees
CEO: Frank Laukien

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...